Marine Compounds and Cancer / / edited by Friedemann Honecker, Sergey A. Dyshlovoy.
The very first marine-derived anticancer drug, Cytarabine (aka Ara-C, Cytosar-U(R)), was approved by the FDA in 1969 for the treatment of leukemia. At the beginning of 2021, the list of approved marine-derived anticancer drugs consists of nine substances, five of which received approval within the l...
Saved in:
| TeilnehmendeR: | |
|---|---|
| Place / Publishing House: | Basel : : MDPI - Multidisciplinary Digital Publishing Institute,, 2018. |
| Year of Publication: | 2018 |
| Language: | English |
| Physical Description: | 1 online resource (v, 110 pages) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 01761nam a2200301 i 4500 | ||
|---|---|---|---|
| 001 | 993561790204498 | ||
| 005 | 20230220214134.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 230220s2018 sz o 000 0 eng d | ||
| 035 | |a (CKB)4920000000094882 | ||
| 035 | |a (NjHacI)994920000000094882 | ||
| 035 | |a (EXLCZ)994920000000094882 | ||
| 040 | |a NjHacI |b eng |e rda |c NjHacl | ||
| 050 | 4 | |a QP632.M37 |b .M375 2018 | |
| 082 | 0 | 4 | |a 615.945 |2 23 |
| 245 | 0 | 0 | |a Marine Compounds and Cancer / |c edited by Friedemann Honecker, Sergey A. Dyshlovoy. |
| 264 | 1 | |a Basel : |b MDPI - Multidisciplinary Digital Publishing Institute, |c 2018. | |
| 300 | |a 1 online resource (v, 110 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 588 | |a Description based on publisher supplied metadata and other sources. | ||
| 520 | |a The very first marine-derived anticancer drug, Cytarabine (aka Ara-C, Cytosar-U(R)), was approved by the FDA in 1969 for the treatment of leukemia. At the beginning of 2021, the list of approved marine-derived anticancer drugs consists of nine substances, five of which received approval within the last two years, demonstrating the rapid evolution of the field. The current book is a collection of scientific articles related to the exponentially growing field of anticancer marine compounds. These articles cover the whole field, from agents with cancer-preventive activity, to novel and previously characterized compounds with anticancer activity, both in vitro and in vivo, as well as the latest status of compounds under clinical development. | ||
| 650 | 0 | |a Cancer |x Radiotherapy. | |
| 650 | 0 | |a Marine toxins. | |
| 776 | |z 3-03842-765-9 | ||
| 700 | 1 | |a Honecker, Friedemann, |e editor. | |
| 700 | 1 | |a Dyshlovoy, Sergey A., |e editor. | |
| 906 | |a BOOK | ||
| ADM | |b 2023-03-01 00:24:22 Europe/Vienna |f system |c marc21 |a 2019-11-10 04:18:40 Europe/Vienna |g false | ||
| AVE | |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337839820004498&Force_direct=true |Z 5337839820004498 |8 5337839820004498 | ||